Duration of Exercise Program in Interstitial Lung Diseases.

Overview

We aimed to compare the functional results of the 8th week with the results of the 12th week of the exercise programs applied to the patients with ILD.

Full Title of Study: “A Comparison Trial of Eight Weeks Versus Twelve Weeks of Exercise Program in Interstitial Lung Diseases.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2016

Detailed Description

Exercise programs (EP) have been shown to be the effective approach for functional outcomes in interstitial lung diseases (ILD). In many studies, the duration of exercise programs varies between 8-12 weeks. However, the optimal duration of exercise program is still unknown. We aimed to compare the results of the 8th week with the results of the 12th week of the PR programs applied to the patients with ILD. A total of 14 patients with ILD referred to our PR unit [11 idiopathic pulmonary fibrosis, 2 sarcoidosis (stage 3 and 4) and 1 nonspecific interstitial pneumonia] were included in the study. Pulmonary function test, arterial blood gas analysis, 6- minute walk test, mMRC dyspnea scale, quality of life questionnaires and hospital anxiety depression scale were performed before, at the 8th and 12th weeks after the exercise program applied to the patients twice a week.

Interventions

  • Other: Exercise program
    • Exercise program including breathing control, pursed-lip breathing, diaphragmatic and thoracic breathing, aerobic and strengthening training

Arms, Groups and Cohorts

  • Other: Exercise program
    • Treatment group

Clinical Trial Outcome Measures

Primary Measures

  • Six minute walk test
    • Time Frame: 6 minute
    • It was performed in a 30-meter long corridor in accordance with American Thoracic Society criteria

Secondary Measures

  • mMRC
    • Time Frame: 5 minutes
    • It was used for dyspnea that patients felt during their daily activities.
  • Pulmonary Function Test
    • Time Frame: 20 minutes
    • It was used for assessment of lung functions
  • SGRQ
    • Time Frame: 30 minutes
    • A disease-specific quality of life scale
  • SF-36 Health Survey
    • Time Frame: 30 minutes
    • A health related quality of life scale
  • Hospital Anxiety and Depression Inventory
    • Time Frame: 20 minutes
    • It was used for assessment of anxiety and depression

Participating in This Clinical Trial

Inclusion Criteria

  • Completed the 12 week exercise program – Diagnosed with ILD Exclusion Criteria:

  • Not completed 12 week exercise program

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Izmir Katip Celebi University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ilknur Naz, Asst. Prof – Izmir Katip Celebi University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.